Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Development of Biocatalytic Strategies for the Synthesis of Chiral Thiols and Thioethers

Descrizione del progetto

Sintesi enzimatica di principi attivi farmaceutici

In chimica, le molecole chirali sono immagini speculari l’una dell’altra. La sintesi dell’enantiomero destro è di particolare importanza, soprattutto per i principi attivi farmaceutici in cui l’effetto biologico del composto è fondamentale. Questa sintesi spesso implica condizioni difficili o metalli tossici ed è quindi inadatta per i composti medici. Finanziato dal programma di azioni Marie Skłodowska-Curie (MSCA), il progetto ThioBioCat sfrutterà il potere degli enzimi in nuovi approcci biocatalitici per la sintesi di principi attivi farmaceutici. Gli enzimi hanno la capacità intrinseca di agevolare la sintesi chimica in modo semplice e rispettoso dell’ambiente e offrono un vantaggio nella produzione di composti destinati all’uso umano.

Obiettivo

Active pharmaceutical ingredients (APIs) are crucial for public health. However, their synthesis is often challenging due to the high complexity of modern drug molecules. In particular, APIs need to have well-defined chirality as opposite enantiomers can have dramatically different biological effects. Yet, the synthesis of chiral centres is often challenging and toxic metals as well as harsh reaction conditions are often required. Enzymes on the other hand can often achieve unmatched enantioselectivities while also avoiding such environmentally unfavourable conditions.
While several biocatalytic strategies for the synthesis of chiral alcohols and amines, have been developed few such strategies exist for the synthesis of chiral thiols and thioethers, despite 20% of all APIs containing sulfur. In the project described herein, I will be developing biocatalytic approaches for the synthesis of thiols and thioethers by exploring promiscuous activities of classes of enzymes widely used in industry. This will expand the tools available for their synthesis and open up new routes and new chemical space for the synthesis of APIs, and improve the sustainability.
While working with Dr Caroline Paul in the Biocatalysis group at TU Delft, I will receive training in handling nicotinamide- and flavin-dependent oxidoreductase enzymes as well as specialist computational tools for enzyme engineering, while providing my experience in high-throughput screening and chemical synthesis. I will have the opportunity to co-supervise Bachelor, Master, and PhD students, and attend several key conferences. This will allow me to further develop the necessary scientific and teaching skills that are required for leading my own research group.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2021-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

TECHNISCHE UNIVERSITEIT DELFT
Contributo netto dell'UE
€ 187 624,32
Costo totale
Nessun dato